首頁 > 雜志
Chinese Herbal Medicines(2022年03期)
中草藥(英文版)
-
- 基本信息
-
：天津藥物研究院長;中國醫(yī)學(xué)科學(xué)院藥用植物開發(fā)研究所
：季刊
：1674-6384
- 出版信息
-
： 醫(yī)藥衛(wèi)生科技
： 中藥學(xué)
：1081篇
- 評(píng)價(jià)信息
-
：0.681
：0.513
：
目 錄
- Traditional Mongolian medicine: Past, present and future
- Mongolian medicine: History, development and existing problems
- Connotation and scientific research points of processing of Mongolian medicinal materials
- Discussion on evolution of Mongolian medicinal material names and countermeasures for standardization
- Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway activation
- Sugemule-10: Source of prescription and modern clinical application
- Famous traditional Mongolian medicine Xieriga-4(Turmeric-4)decoction: A review
- Phytochemical and pharmacological progress on Syringa oblata,a traditional Mongolian medicine
- Emerging therapeutic role of Prunella vulgaris in thyroid disease
- Metabolomics investigation on antiobesity effects of Corydalis bungeana on high-fat high-sugar diet-induced obese rats
- Metabonomics study of liver and kidney subacute toxicity induced by garidi-5 in rats
- Assessment of pulmonary infectious disease treatment with Mongolian medicine formulae based on data mining,network pharmacology and molecular docking
- Tea and Citrus maxima complex induces apoptosis of human liver cancer cells via PI3K/AKT/mTOR pathway in vitro
- Chemical constituents of Lomatogonium carinthiacum and Halenia corniculata
- Rapid quantitative analysis of 12 chemical constituents in wild-simulated and cultivated Astragali Radix based on UHPLC-MS
- Words for Cover Figure
- Asari Radix et Rhizoma consumption lacks relevance for hepatocellular carcinoma in patients:A retrospective cohort study
- Instruction for Authors
- Ethical Guideline to Authors,Editors,and Reviewers
